Breastfeeding and HIV transmission in the developing world: Past, present, future

Current Opinion in HIV and AIDS

Volumn 8, Issue 5, 2013, Pages 467-473

  Rollins, Nigel ^a,b   Coovadia, Hoosen M ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

antiretroviral drugs; breastfeeding; HIV; mortality; transmission

Indexed keywords

ANTIRETROVIRUS AGENT;

BREAST FEEDING; CHILDHOOD MORTALITY; DEVELOPING COUNTRY; DIARRHEA; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; INFECTION PREVENTION; MALNUTRITION; MATERNAL MORTALITY; MATERNAL WELFARE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 84883450809     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283632ba2     Document Type: Review

References (64)

1. Sidibe M, Piot P, Dybul M. AIDS is not over. Lancet 2012; 380:2058-2060.
2. Sabbaj S, Ibegbu CC, Kourtis AP. Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant. Adv ExpMed Biol 2012; 743:161-169.
3. Belec L, Kourtis AP. B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1. Adv Exp Med Biol 2012; 743:139-160.
4. Lepage P, Van de Perre P. The immune system of breast milk: antimicrobial and anti-inflammatory properties. Adv Exp Med Biol 2012; 743:121-137.
5. Fiscus SA, Aldrovandi GM. Virologic determinants of breast milk transmission of HIV-1. Adv Exp Med Biol 2012; 743:69-80.
6. Rollins N, Mahy M, Becquet R, et al. Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect 2012; 88 (Suppl 2):i44-i51.
7. Humphrey JH, Marinda E, Mutasa K, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ 2010; 341:c6580.
8. Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2012; 59:417-425.
9. Semrau K, Kuhn L, Brooks DR, et al. Dynamics of breast milk HIV-1 RNA with unilateral mastitis or abscess. J Acquir Immune Defic Syndr 2012. [Epub ahead of print]
10. Kuhn L, Kim HY, Walter J, et al. HIV-1 concentrations in human breast milk before and after weaning. Sci Transl Med 2013; 5:181ra51.
11. Fouda GG, Mahlokozera T, Salazar-Gonzalez JF, et al. Postnatally- transmitted HIV-1 envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants. Retrovirology 2013; 10:3.
12. Ndirangu J, Viljoen J, Bland RM, et al. Cell-free (RNA) and cell-associated (DNA) HIV-1 and postnatal transmission through breastfeeding. PLoS ONE 2012; 7:e51493.
13. Van de Perre P, Rubbo PA, Viljoen J, et al. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med 2012; 4:143sr3.
14. Mabuka J, Nduati R, Odem-Davis K, et al. HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog 2012; 8:e1002739.
15. Bode L, Kuhn L, Kim HY, et al. Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding. Am J Clin Nutr 2012; 96:831-839.
16. Lyimo MA, Mosi MN, Housman ML, et al. Breast milk from Tanzanian women has divergent effects on cell-free and cell-associated HIV-1 infection in vitro. PLoS ONE 2012; 7:e43815.
17. Henrick BM, Nag K, Yao XD, et al. Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. PLoS ONE 2012; 7:e40138.
18. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007; 369:1107-1116.
19. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19:699-708.
20. Rossenkhan R, Novitsky V, Sebunya TK, et al. Infant feeding practices were not associated with breast milk HIV-1 RNA levels in a randomized clinical trial in Botswana. AIDS Behav 2012; 16:1260-1264.
21. Neveu D, Viljoen J, Bland RM, et al. Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin Infect Dis 2011; 52:819-825.
22. Aizire J, Fowler MG, Coovadia HM. Operational issues and barriers to implementation of prevention of mother-to-child transmission of HIV (PMTCT) interventions in sub-Saharan Africa. Curr HIV Res 2013; 11:144-159.
23. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010; 362:2271-2281.
24. Jamieson DJ, Chasela CS, Hudgens MG, et al. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet 2012; 379:2449-2458.
25. Taha TE, Li Q, Hoover DR, et al. Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial. J Acquir Immune Defic Syndr 2011; 57:319-325.
26. Study Team SWEN, Bedri A, Gudetta B, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008; 372:300-313.
27. Coovadia HM, Brown ER, Fowler MG, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 221-228.
28. Hudgens MG, Taha TE, Omer SB, et al. Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Clin Infect Dis 2013; 56:131-139.
29. Kilewo C, Karlsson K, Massawe A, et al. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. J Acquir Immune Defic Syndr 2008; 48:315-323.
30. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010; 362:2282-2294.
31. Kesho Bora Study Group. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/singledose nevirapine prophylaxis): The Kesho Bora randomized controlled trial. Clin Infect Dis 2012; 55:449-460.
32. Palombi L, Pirillo MF, Andreotti M, et al. Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety. Antivir Ther 2012; 17:1511-1519.
33. Okonji JA, Zeh C, Weidle PJ, et al. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya. J Acquir Immune Defic Syndr 2012; 61:249-257.
34. Centers for Disease Control Prevention (CDC). Impact of an innovative approach to prevent mother-to-child transmission of HIV: Malawi, July 2011-September 2012MMWRMorb Mortal Wkly Rep 2013; 62:148-151.
35. Coutsoudis A, Goga A, Desmond C, et al. Is Option B\+ the best choice? Lancet 2013; 381:269-271.
36. Gamell A, Letang E, Jullu B, et al. Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change. Swiss Med Wkly 2013; 143:0.
37. Lazarus R, Struthers H, Violari A. Promoting safe infant feeding practices-the importance of structural, social and contextual factors in Southern Africa. J Int AIDS Soc 2013; 16:18037.
38. Andreson J, Dana N, Hepfer B, et al. Infant feeding buddies: a strategy to support safe infant feeding for HIV-positive mothers. J Hum Lact 2013; 29:90-93.
39. Ijumba P, Doherty T, Jackson D, et al. Social circumstances that drive early introduction of formula milk: an exploratory qualitative study in a peri-urban South African community. Matern Child Nutr 2012; doi: 10.1111/mcn.12012. [Epub ahead of print]
40. Ciaranello AL, Perez F, Engelsmann B, et al. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis 2013; 56:430-446.
41. Ochola SA, Labadarios D, Nduati RW. Impact of counselling on exclusive breast-feeding practices in a poor urban setting in Kenya: a randomized controlled trial. Public Health Nutr 2012; 1-9.
42. Eamer GG, Randall GE. Barriers to implementing WHO's exclusive breastfeeding policy for women living with HIV in sub-Saharan Africa: an exploration of ideas, interests and institutions. Int J Health Plann Manage 2012; doi: 10.1002/hpm.2139. [Epub ahead of print]
43. Chinkonde JR, Hem MH, Sundby J. HIV and infant feeding in Malawi: public health simplicity in complex social and cultural contexts. BMC Public Health 2012; 12:700.
44. Adler MR, Brewinski M, Heap AN, Bolu O. The role of the President's Emergency Plan for AIDS Relief in infant and young child feeding guideline development and program implementation. Adv Exp Med Biol 2012; 743:247-260.
45. Bork K, Cames C, Cournil A, et al. Infant feeding modes and determinants among HIV-1-infected African Women in the Kesho Bora Study. J Acquir Immune Defic Syndr 2013; 62:109-118.
46. Gartland MG, Chintu NT, Li MS, et al. Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural Zambia. AIDS 2013; 11:144-159.
47. Natchu UC, Liu E, Duggan C, et al. Exclusive breastfeeding reduces risk of mortality in infants up to 6 mo of age born to HIV-positive Tanzanian women. Am J Clin Nutr 2012; 96:1071-1078.
48. Parker ME, Tembo M, Adair L, et al. The health of HIV-exposed children after early weaning. Matern Child Nutr 2013; 9:217-232.
49. Taha TE, Hoover DR, Chen S, et al. Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi. Clin Infect Dis 2011; 53:388-395.
50. Tylleskar T, Jackson D, Meda N, et al. Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a clusterrandomised trial. Lancet 2011; 378:420-427.
51. Binagwaho A, Pegurri E, Drobac PC, et al. Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda. PLoS ONE 2013; 8:e54180.
52. Ndirangu J, Newell ML, Tanser F, et al. Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS 2010; 24:593-602.
53. Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013; 339:961-965.
54. World Health Organization. Consolidated Guidelines on Antiretroviral Drugs. 2013. http://www who int/hiv/pub/(in press).
55. Saloojee H, Gray G, McIntyre J. HIV and infant feeding: one step forward, two steps back. S Afr J HIV Med 2011; 42:6-10.
56. John-Stewart G, Nduati R. Should women with HIV-1 infection breastfeed their infants? It depends on the setting. Adv Exp Med Biol 2012; 743:289-297.
57. Mahy M, Stover J, Kiragu K, et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010; 86 (Suppl 2): ii48-ii55.
58. Read JS. Non-antiretroviral approaches to prevention of breast milk transmission of HIV-1: exclusive breastfeeding, early weaning, treatment of expressed breast milk. Adv Exp Med Biol 2012; 743:197-204.
59. Hoque SA, Hoshino H, Anwar KS, et al. Transient heating of expressed breast milk up to 65 degrees C inactivates HIV-1 in milk: a simple, rapid, and costeffective method to prevent postnatal transmission. J Med Virol 2013; 85:187-193.
60. Young S, Leshabari S, Arkfeld C, et al. Barriers and promoters of home-based pasteurization of breastmilk among HIV-infected mothers in Greater Dar es Salaam, Tanzania. Breastfeed Med 2013; 8:321-326.
61. Chantry CJ, Young SL, Rennie W, et al. Feasibility of using flash-heated breastmilk as an infant feeding option for HIV-exposed, uninfected infants after 6 months of age in urban Tanzania. J Acquir Immune Defic Syndr 2012; 60:43-50.
62. Gerrard SE, Baniecki ML, Sokal DC, et al. A nipple shield delivery system for oral drug delivery to breastfeeding infants: microbicide delivery to inactivate HIV. Int J Pharm 2012; 434:224-234.
63. Lohman-Payne B, Slyker J, Rowland-Jones SL. Immune approaches for the prevention of breast milk transmission of HIV-1. Adv Exp Med Biol 2012; 743:185-195.
64. Becquet R, Marston M, Dabis F, et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS ONE 2012; 7:e28510.